What companies are BIS's competitors?

ProShares - UltraShort Nasdaq Biotechnology (BIS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does BIS compare to its peers?

The peer comparison table on this page shows ProShares - UltraShort Nasdaq Biotechnology (BIS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does BIS operate in?

ProShares - UltraShort Nasdaq Biotechnology (BIS) operates in the Asset Management - Leveraged industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

BIS

ProShares - UltraShort Nasdaq Biotechnology

NASDAQ·Asset Management, Leveraged · Financial Services

$13.87$0.17+1.21%

After hours·$13.84−0.22%

Market cap$2.24M·Market closed·Jul 24 8:00 PM UTC

Frequently Asked Questions About BIS

What companies are BIS's competitors?: ProShares - UltraShort Nasdaq Biotechnology (BIS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BIS compare to its peers?: The peer comparison table on this page shows ProShares - UltraShort Nasdaq Biotechnology (BIS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BIS operate in?: ProShares - UltraShort Nasdaq Biotechnology (BIS) operates in the Asset Management - Leveraged industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

BIS

ProShares - UltraShort Nasdaq Biotechnology

NASDAQ·Asset Management, Leveraged · Financial Services

$13.87$0.17+1.21%

After hours·$13.84−0.22%

Market cap$2.24M·Market closed·Jul 24 8:00 PM UTC

Peers


EMTY	ProShares - Decline of the Retail Store ETF	$24.83	$3.1M
WDNA	WisdomTree BioRevolution Fund	$20.03	$2.6M
PEVC	Pacer PE/VC ETF	$29.48	$2.4M
SCC	ProShares UltraShort Consumer Discretionary	$16.76	$2.3M
XXCH	Direxion Daily MSCI Emerging Markets ex China Bull 2X Shares	$33.09	$2.2M
BOED	Direxion Daily BA Bear 1X ETF	$17.53	$2.1M
SMDD	ProShares - UltraPro Short MidCap400	$8.02	$1.9M
CSCS	Direxion Daily CSCO Bear 1X ETF	$13.67	$1.6M
XOMZ	Direxion Daily XOM Bear 1X ETF	$16.90	$1.5M
BULG	Leverage Shares 2x Long BULL Daily ETF	$45.47	$645.8K

Frequently Asked Questions About BIS

What companies are BIS's competitors?: ProShares - UltraShort Nasdaq Biotechnology (BIS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BIS compare to its peers?: The peer comparison table on this page shows ProShares - UltraShort Nasdaq Biotechnology (BIS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BIS operate in?: ProShares - UltraShort Nasdaq Biotechnology (BIS) operates in the Asset Management - Leveraged industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.